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We employed radioligand binding autoradiography to determine the distributions of pre- and post- 
synaptic cholinergic radioligand binding sites in the brains of two species of bat, one species of 
shrew, and the rat. High affinity choline uptake sites were measured with [3H]hemicholinium, and 
presynaptic cholinergic vesicles were identified with [3H]vesamicol. Muscarinic cholinergic recep- 
tors were determined with [3H]scopolamine. The distribution patterns of the three cholinergic 
markers were simitar in all species examined, and identified known major cholinergic pathways 
on the basis of enrichments in both pre- and postsynaptic markers. In addition, there was excellent 
agreement, both within and across species, in the regional distributions of the two presynaptic 
cholinergic markers. Our results indicate that pharmacological identifiers of cholinergic pathways 
and synapses, including the cholinergic vesicle transport site, and the organizations of central 
nervous system cholinergic pathways are phylogenetically conserved among eutherian mammals. 
KEY WORDS: Vesamicol; hemicholinium-3; scopolamine; muscarinic receptor; high-affinity choline uptake; 
cholinergic vesicle. 
I N T R O D U C T I O N  
The anatomy and connections of cholinergic neu- 
rons within the central nervous system have been the 
subject of intense scrutiny within the last decade. Ana- 
tomic, pharmacologic, and human clinical studies have 
emphasized the importance of cholinergic mechanisms 
in memory and cognition (1,2), motor performance (3), 
and in the regulation of sleep and arousaI (4). From a 
comparative perspective, acetylcholine is utilized as a 
neurotransmitter throughout the animal kingdom (see 
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Wachtler (5) for review). While cholinergic pathways 
have been extensively studied in select mammals (6-9), 
there is little data on the organization of cholinergic path- 
ways in other vertebrates. 
The available data suggest tha~ all vertebrates ex- 
amined to date possess a ventral compiex of cholinergic 
neurons homologous to the mammalian magnocellular 
basal forebrain nuclei. This region is implicated in the 
provision of most cholinergic innervation of the cerebral 
cortex (10). Studies of some reptiles, however, have 
shown that the distribution of cholinergic neurons and 
neuropil within the striatal and hippocampal homologues 
differs from that found in mammals (11-13). In addition, 
recent studies indicate that the regulation of striatal cho- 
linergic activity in reptiles differs from that found in rats 
(14,15). Due to the limited number of mammals and 
non-mammalian vertebrates studied, it is unclear whether 
these anatomic and functional distinctions reflect differ- 
ences between classes of vertebrates or, alternatively, 
species variations within classes. In the present studies, 
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we address one aspect of this issue by employing radi- 
oligand binding autoradiography to quantify the distri- 
bution of pre- and postsynaptic cholinergic markers in 
the brains of previously unstudied eutherian mammals. 
These results are compared with data obtained simulta- 
neously in rats. In addition, the distribution of a rela- 
tively new putative presynaptic cholinergic marker, the 
binding of pH]vesamicol to the presynaptic cholinergic 
vesicle (16), is evaluated in direct comparison to the 
more traditionally-employed distribution of sodium-de- 
pendent, high-affinity transmembrane choline uptake sites, 
identified by [3H]hemicholinium-3 binding (17). 
and cerebellar cortex. In the two species of bat, striatal measurements 
were determined from the average of the caudate nucleus and the 
putamen. 
Phylogenetic similarities in the regional distributions of binding 
sites were explored with the use of regression analysis, performed 
between species. As cholinergic pathways of the rat have been studied 
extensively, regional binding levels in both species of bats and shrew 
brain were compared with those of the rat. In addition, the patterns of 
the three putative cholinergic markers were compared with one another 
within each species to assess relationships between the two presynaptic 
sites, and between pre- and postsynaptic indices. Statistical analyses 
of regional binding correlations were accomplished employing a linear 
regression model (SigmaStat program, Jandel Scientific, San Rafael, 
CA). 
EXPERIMENTAL PROCEDURE RESULTS 
Materials. Tritiated scopolamine (30 Ci/mmol), obtained by cus- 
tom labelling, and tritium-sensitive X-ray film (Hyperfilm) were pur- 
chased from Amersham (Arlington Hts, IL). Tritiated vesamicol (49 
Ci/mmol) and pH]hemicholinium-3 (137 Ci/mmol) were purchased 
from DuPont-New England Nuclear (Boston, MA). 
Animals and Tissue Preparation. Four Egyptian Tomb bats (Rou- 
settus egypticus), four Whispering bats ( Carrollia perspicalata), two 
Short-Tailed shrews (Blarina brevicauda), and four Sprague-Dawley 
rats (Rattus rattus) were used. Animals were decapitated, the brains 
rapidly extracted from the cranial vault, frozen in crushed dry ice, 
coated with frozen section embedding matrix (Lipshaw, Detroit, MI), 
and stored at - 70~ At the time of sectioning, brains were warmed 
to -20~ and 20 micron-thick coronal sections were thaw-mounted 
onto gelatin-coated slides, air-dried, and stored at - 70~ until assay. 
Ligand BindingAutoradiography. Binding assays were performed 
on adjacent sections from selected levels of each brain. Each assay 
consisted of: 1) a 5 min pre-incubation at 25~ to remove endogenous 
ligands; 2) incubation with labelled ligand at 25~ and 3) post-wash 
at 4~ to reduce non-specific binding. Phosphate buffered saline con- 
taining EDTA (137 mM NaCI, 3 mM KCI, 8 mM NazHPO4, 1.5 mM 
KHzPO 4 and 1 mM EDTA; pH 7.4) was used in all assays. 
Muscarinic receptors were labeled after incubation in 10 nM 
[3H]scopolamine for 30 minutes and received a 10 minute post-wash 
(18). Cholinergic vesicle transport sites were labeled after incubation 
in 20 nM [3H]vesamicol for 60 minutes, followed by a 2 minute post- 
wash (19,20). High affinity, sodium-dependent transmembrane choline 
uptake sites were labeled after incubation in 10 nM [3H]hemicholinium- 
3 for 120 minutes, followed by a 2 minute post-wash (21,22). 
Sections were air-dried and apposed to tritium-sensitive fiJm in 
light tight X-ray cassettes. Standards containing known amounts of 
radioactivity were co-exposed with the sections. Films were exposed 
for 2 (scopolamine and vesamicol) or 4 (hemicholinium-3) weeks, and 
then developed in Kodak D-19. 
Data Analysis. Autoradiograms were analyzed by computer-as- 
sisted densitometry (MCID System, Imaging Research; St. Catherines, 
ONT). Film optical density was converted to tissue radioactivity con- 
centration using a regression curve derived from radioactive standards 
exposed on each film (23). Brain regions identified included areas with 
anticipated high and low levels of cholinergic markers, on the basis 
of prior rodent and primate studies, and included the interpeduncular 
nucleus, basolateral amygdala, striatum, dentate gyrus, CA1 field of 
the hippocampus, CA3 field of the hippocampus, frontal cortex, oc- 
cipital cortex, superficial layers of the superior colliculus, thalamus, 
Presynaptic Cholinergic Marker Distributions. 
Similar patterns of individual cholinergic marker distri- 
butions were observed across the brains of each species 
examined (Table I; Figs. 2-5). In addition to cross-spe- 
cies similarity in [3H]hemicholinium-3 and [3H]vesamicol 
binding distributions, the pattern of these two putative 
presynaptic markers was qualitatively concordant within 
each species examined (Fig 1A). The regional density 
of muscarinic receptors, however, was not correlated 
with the level of the presynaptic markers (Fig 1B). 
The interpeduncular nucleus has the highest levels 
of both vesamicol and hemicholinium-3 binding of the 
quantified regions, with the exception of hemicholinium- 
3 binding in Rousettus egypticus, in which the nucleus 
was not reliably represented in the sections assayed. The 
striatum and basolateral amygdala have the next highest 
levels, with lower levels of binding observed in the hip- 
pocampal formation, neocortex, and superior colliculus. 
Lowest levels of binding were observed in the ventral 
Table I. Inter-Species Correlation Analyses of Cholinergic Marker 
Distributions" 
Hemicholin- 
Vesamicol ium-3 Scopolamine 
Whispering Bat 
(C, perspicalata) 0.565 b 0.783 0.849 
Tomb Bat 
(R. egypticus) 0.942 0.810 0.894 
Shrew 
(B. Brevicauda) 0.827 0.997 0.885 
Values are correlation coefficients (r a) resulting from linear regres- 
sion analyses of ligand binding in rat (R. rattus) versus comparison 
species. All correlations are statistically significant at the P < 0.001 
level, except where otherwise noted. 
b Correlation significant at the P < 0.01 level. 
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Fig. 1. Comparison of different cholinergic synaptic marker distribu- 
tions within individual species. (A) Comparison of the regional binding 
of the presynaptic cholinergic markers hemicholinium-3 and vesamicol 
within corresponding brain regions in rat (circles), shrew (squares), 
Tomb bat (triangles) and Whispering bat (inverted triangles) brains. 
Data points represent the means of ligand binding in corresponding 
regions, expressed as apparent fmol4zg protein. Lines representing 
results of linear regression analyses for each species are additionally 
depicted. There is good correspondence of the two indices in each 
species studied (correlation coefficients: 0.71 to 0.96, P < 0.001). A 
tendency for higher levels of vesamicol binding in regions with low- 
to-modest hemicholinium-3 binding is noted in the Whispering bat 
(abscissa intercept 1.12 fmol/txg protein) in comparison to the other 
species (abscissa intercepts 0.19 to 0.55 fmol/p.g protein). (B) Com- 
parison of presynaptic (hemicholin/um-3) and predominantly postsyn- 
@tic (scopolamine) marker binding within individual species, There 
are no significant correlations (P > 0.2 to 0.6) between the two in- 
dices. 
and lateral thalamic nucIei and in cerebellar cortex (Ta- 
ble II). 
Muscarinic Receptor Distribution As detailed pre- 
viously for the presynaptic cholinergie binding sites, the 
general pattern of muscarinic receptor binding was qual- 
itatively similar across all of the species examined (Table 
I; Figs. 2-5). The CA1 hippocampal subfield, followed 
either by the striatum or dentate gyrus of the hippocam- 
pus have highest receptor densities in all species (Table 
II). The basolateral amygdala, remaining fields of the 
hippocampus, neocortex and superior colliculus follow 
in varying rank order of progressively lower receptor 
concentration. The ventral thalamic nuclei, interpedun- 
cular nucleus and the cerebellum have the lowest levels 
of binding of the quantified regions. 
DISCUSSION 
The animals studied in this report were chosen to 
represent a broad phylogenetic spectrum. Shrews, so- 
called "basal" insectivores, share many similarities with 
primitive Jurassic mammals that are the presumed pro- 
genitors of all extant mammals, and are felt to represent 
the closest contemporary analogue of ancestral mammals 
(24). Bats, one of of the most specialized of modern 
mammalian orders, are additionally among the most suc- 
cessful, represented by a contemporary species diversity 
surpassed only by rodents. Although the precise se- 
quence of mammalian phylogeny is presently unknown, 
paleontologic evidence indicates that bats attained mod- 
ern characteristics early in the post-Cretaceous mam- 
malian radiation and have subsequently undergone 
considerable morphologic diversification and adaptation 
(25). Thus, the representatives selected for study in the 
present work represent both "'primitive" and "highly 
evolved" mammals, allowing the comparison of a di- 
verse range of species. 
Interpretation of our studies rests on the assumption 
that binding assays of cholinergic markers, often devel- 
oped and pharmacologically characterized in rat, identify 
homologous binding sites in bat and shrew brains. Direct 
verification of this assumption would require an exten- 
sive series of pharmacologic and kinetic studies, beyond 
the scope of the present work. However, the binding 
sites under study have been examined in other species, 
and are found to possess similar characteristics. 
The binding of hemicholinium-3, characterized ini- 
tially in rodent (17,21,22), has been additionally re- 
ported in studies of lagomorph (26) and primate (27) 
brains. The cumulative results with pH]hemicholinium- 
3 support the association of its saturable, high-affinity 
binding site with the chemically-defined presynaptic, so- 
dium-dependent, high-affinity choline transporter. Our 
present results are in agreement with prior reports in 
other species, suggesting the presence and enrichment 
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Table II. Regional Distributions of Hemicholinium-3, Vesamicol, and Scopolamine Binding Sites" 
i i i 
[3H]Hemicholinium-3 Binding 
Species 
Brain Rat Whispering Bat Tomb Bat Shrew 
Region ~' (R. rattus) ( C. perspicalata ) (R. egypticus) (B. Brevicauda ) 
CTX 0.10 (0.02) 0.24 (0.02) 0.11 (0.01) 0.10 (0.03) 
CA1 0.10 (0.01) 0.33 (0.02) 0.10 (0.02) 
CAB 0.11 (0.01) 0.46 (0.07) ~' 0.20 (0.05) 0.10 e 
DO 0.14 (0.02) 0.38 (0.06) 0.18 (0.02) 0.12 e 
STR 0.49 (0.06) c 0.98 (0.09) 0.42 (0.07) 0.35 (0.15) 
BLA 0.49 (0.03) 0.96 (0.03) '~ 0.87 (0.06) c 
VTH 0.07 (0.01) 0.07 (0.01) 0.07 (0.01) ~ 0.07 (0.03) 
SC 0.11 (0.02) 0.16 (0.01) 0.10 (0.01) C 0.08 e 
IPN 1.53 (0.20) e 1.34 (0.61) 'j 1.27 r 
CBL 0.05 (0.01) 0.08 (0.02) 0.06 (0.01) 0.06 (0.01) 
[3H]Vesamicol Binding 
Species 
Brain Rat Whispering Bat Tomb Bat Shrew 
Region b (R. rattus) (C. perspicalata) (R. egypticus) (B. Brevicauda) 
CTX 0.33 (0.04) 1.53 (0.35) 0.38 (0.11) 0.63 (0.19) 
CA1 0.43 (0.08) 1.80 (0.15) 0.42 (0.15) 0.72 (0.22) 
CA3 0.60 (0.14) 2.32 (0.14) 0.65 (0.13) 1.23 (0.19) 
DG 0.57 (0.09) 2.25 (0.26) 0.61 (0.12) c 0.97 (0.28) 
STR 1.21 (0.20) 2.07 (0.12) 0.76 (0.13) 1.42 e 
BLA 1.71 (0.30) 2.60 (0.15) c 1.23 (0.34) 0.87 e 
VTH 0.21 (0.08) 1.24 (0.31) 0.29 (0.t4) 
SC 0.35 (0.03) 1.38 (0.45) 0.44 (0.13) ~ 0.79 (0.25) 
IPN 3.28 (0.38) d 2.70 (0.14) c 1.59 (0.64) ~ 3.69 e 
CBL 0.23 (0.06) 1.00 (0.42) 0.47 (0.15) 0.42 (0.03) 
pH]Scopolamine Binding 
Species 
Brain Rat Whispering Bat Tomb Bat Shrew 
Region b (R. rattus) (C. perspicalata) (R. egypticus) (B. Brevicauda) 
CTX 2.89 (0.26) 3.49 (0.47) 3.80 (0.30) ~ 3.94 (0.05) 
CA1 5.05 (0.21) 6.50 (1.25) 4.98 (2.03) 7.29 (0.44) 
CA3 2.41 (0.i0) 5.02 (0.71) 3.19 (1.15) 5.34 (0.14) 
DG 4.47 (0.16) 4.85 (0.43) 3.56 (1.33) 6.16 (0.02) 
STR 3.71 (0.46) 6.14 (0.59) d 3.83 (0.42) 5.12 (0.15) 
BLA 3.64 (0.37) c 4.31 (0.32) a 2.82 (1.17) 
VTH 0.85 (0.10) 0.78 (0.08) ~ 0.73 (0.25) 0.3& 
SC 1.02 (0.07) 0.48 (0.07) 0.92 (0.02) c 0.77 (0.11) 
IPN 0.82 (0.33) 0.49 (0.36) c 0.63 (0.23) c 
CBL 0.09 (0.01) 0.07 (0.06) ~ 0.10 (0.02) 0.08 (0.01) 
" Values represent means (SD) of radioligand binding, expressed in units of apparent fmol/ixg protein, as determined from densitometric analyses 
of autoradiograms from brains of rat, Whispering bat, Tomb bat (n = 4 each), and shrew (n = 2). 
b Anatomic abbreviations as in the legend to Fig. 2 
n = 3 subjects 
n = 2 subjects 
e n = 1 subject 
of  hemichol in ium-3  binding sites in putat ive chol inergic  
synapt ic  terminal  fields.  
Vesamico l  b inding to the chol inergic  presynapt ic  
ves ic le  was  or iginal ly  described in preparat ions f rom the 
electric organ of  Torpedo  cal i fornicus  (28), and subse- 
quent ly  evaluated in greater  detail in rat brain (20). The 
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Fig. 2. Autoradiographic distributions of cholinergic markers in the rat brain. Coronal brain sections from comparable levels of the rat brain depict 
the binding of [3H]scopolamine (top row), [3H]vesamicol (middle row) and [3H]hemicholinium-3 (bottom row). Anatomic levels range from rostral 
(left column) to caudal (right column) for each marker. Anatomic regions quantified by densitometry are indicated in the hemicholinium-3 images: 
CTX-cerebral cortex; STR-striatum; BLA-basolateraI amygdala; CA1 and CA3-hippocampal subfields; DG-dentate gyrus of the hippocampus; 
VTH-ventral thalamus; IPN-interpeduncular nucleus; SC-superficial superior colliculus; CBL-cerebellum. 
basic characteristics of binding and competition by un- 
labeled drugs are conserved across these studies, sug- 
gesting wide phylogenetic conservation of the cholinergic 
presynaptic vesicle and at least some of its individual 
protein constituents. Limited studies have been con- 
ducted with [3H]vesamicol in human postmortem sam- 
ples (29,30) which suggest a distribution of the binding 
site similar to that described in rat brain. The results 
obtained in the current sample of mammalian brains fur- 
ther support the association of [3H]vesamicol binding 
sites with cholinergic presynaptic terminals, on the basis 
of the regional pattern of binding. It is notable, however, 
that a substantial diffuse background binding of vesam- 
icol binding is found in the Whispering bat, relative to 
other species. This may reflect a component of binding 
to a secondary, unrelated (non-cholinergic) site, termed 
the vesamicol binding protein (31). 
Muscarinic cholinergic receptors have been studied 
in a few non-mammalian species (32-34), and found to 
have properties similar to those defined in rat brain, in- 
dicating phylogenetic conservation of this binding site. 
The pharmacologic profile of [3H]quinuclidinyl benzilate 
binding is comparable, for instance, between the house 
fly head and the rat brain (35). The regional distribution 
of muscarinic receptors has been reported in a variety of 
mammalian brains, including rat (18,36,37), monkey (38), 
and human (39). Our current findings are in agreement 
with these prior studies, indicating high concentrations 
of receptors in most forebrain regions receiving cholin- 
ergic input (see below). 
Cholinergic pathways of the central nervous system 
have been extensively studied in rat (8,9) and to a lesser 
extent in monkey (7) and cat (6). Cholinergic innervation 
of the cerebral cortex is provided by basal forebrain mag- 
nocellular neurons, which project to the hippocampal 
formation, neocortex, amygdala, and olfactory bulb. A 
similar organization is indicated for the species studied 
in the present report, on the bases of presynaptic cholin- 
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Fig. 3. Autoradiographic distributions of cholinergic markers in the shrew brain. Scopolamine, vesamicol, and hemicholinium-3 binding are depicted 
in the top through bottom rows, respectively. The left column of sections is at the level of the striatum, the middle column is at the level of the 
interpeduncular nucleus, and the tight'column is at the cerebellar level. Intense, focal vesamicol binding is observed in the nuclei of the facial 
nerve (ventral aspect of the middle section in the right-most column). Comparable hemicholinium-3 binding is not evident, since the nuclei are not 
present in the more caudal section at the bottom right. 
ergic markers identified in neocortical and hippocampal 
regions. 
A dense plexus of innervation, arising from cholin- 
ergic interneurons, is an outstanding feature of the stria- 
turn (caudate nucleus, nucleus accumbens, putamen, and 
olfactory tubercle) in all mammalian species examined 
to date. This accounts for the high striatal levels of cho- 
linergic markers including cholineacetyltransferase, ac- 
etylcholinesterase, high-affinity choline uptake, and of 
the transmitter acetylcholine itself (40). Our present re- 
sults confirm that this aspect of striatal neurochemistry 
is representative of most mammalian brains, since the 
striatum is among the highest in levels of hemicholi- 
nium-3 and vesamicol binding sites observed. 
Brainstem cholinergic nuclei include the centrally- 
projecting pontine paramedian and paraventricular nuclei 
(41,42), as well as nuclei of motor cranial nerves. The 
former group sends ascending projections to thalamic 
and subcortical telencephalic targets. These nuclei and 
their terminal fields were not represented regularly in the 
tissues examined in the present, and were thus not sub- 
jected to quantification. Nevertheless, anterior and in- 
tralaminar thalamic nuclei as well as motor cranial nerve 
nuclei were identified sporadically in our data sets, dis- 
tinguished by both pre- and postsynaptic cholinergic in- 
dices. Future studies will require more intensive anatomic 
sampling to better define these nuclei and projections. 
Finally, our results identify a number of areas with 
discordant pre- and postsynaptic indices, particularly ev- 
ident in diencephalic and brainstem nuclei. These re- 
gions are exemplified by the interpeduncular nucleus, 
which expresses intense presynaptic marker labeling. Ef- 
ferent cholinergic fibers are believed to originate within, 
or alternatively traverse via fibers of passage, the ha- 
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Fig. 4. Autoradiographic distributions of cholinergic markers in the Tomb bat brain. Scopolamine, vesamicol, and hemicholinium-3 binding are 
depicted in the top through bottom rows, respectively. The rostro-caudal levels of each of the columns correspond to the levels depicted in Fig. 2, 
with the exception that the interpeduncular nucleus is not well-represented (third column of sections) at this slightly more caudal level than that 
represented in the rat autoradiograms. 
benula, and further travel in the habenulo-interpedun- 
cular tract (8). We observed high levels of both presynaptic 
binding sites in our studies, despite only minor levels of 
muscarinic receptors. This apparent mismatch may in- 
dicate distinct expression levels or regulation of the 
muscarinic receptor populations across brain regions, or 
may indicate predominance of nicotinic postsynaptic 
mechanisms in the interpeduncular system (43). Many 
of the areas with varying degree of apparent mismatch 
are known to express high levels of nicotinic acetylcho- 
line receptors, including the interpeduncular nucleus, 
dorsal thalamus and the superior and inferior colliculi 
(44). 
In summary, the present results suggest that the 
organization of cholinergic pathways in two species of 
bat and one shrew is similar to that of the rat. Both 
cholinergic innervation and muscarinic cholinergic re- 
ceptor distribution patterns are similar in these four phy- 
logenetically diverse mammals. In further preliminary 
experiments, we have found a corresponding anatomic 
distribution of pre- and postsynaptic markers in the brain 
of a marsupial (the Virginia opossum, Didelphis virgi- 
niana). As the organization of cholinergic pathways of 
the rodent is similar to that of primate and carnivore, 
the combined data suggest that its general features are 
characteristic of all eutherian mammals. Furthermore, as 
some data indicate differences between mammals and 
reptiles in the distribution of cholinergic neuropil within 
the striatal and hippocampal homologues, it is likely that 
the pattern of cholinergic organization observed in our 
studies is unique to the mammalian radiation. The strong 
conservation of anatomic homology in cerebral cholin- 
ergic pathways among mammals suggests that the func- 
tions subserved by cholinergic activity may also be similar, 
although further pharmacologic and physiologic studies 
will be necessary to explore this hypothesis. 
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Fig. 5. Autoradiographic distributions of cholinergic markers in the Whispering bat brain. Scopolamine, vesamicol, and hemicholinium-3 binding 
are depicted in the top through bottom rows, respectively. The mstro-caudal levels of each of the columns correspond to the levels depicted in Fig. 
2. Note the generally higher levels of vesamicol binding in regions of low-to-moderate hemicholinium-3 binding (cerebral cortex, thalamus, 
cerebellum) than are observed in the other species studied. 
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